Search COVID-19 Rapid Resource Center or explore resources sorted by Category or Content Type.
Dexmedetomidine-Associated Hyperpyrexia in Three Critically Ill Patients With Coronavirus Disease 2019
Crisis Management, Pharmacology,
From Critical Care Explorations
In this study of three patients, the authors state that their findings suggest that high doses of dexmedetomidine infusion are associated with hyperpyrexia in a seemingly dose-dependent fashion in critically ill patients with coronavirus disease 2019.
Czepiel KS, Lucas AT, Whalen MJ, et al.
Estimated Time: 15:48